Literature DB >> 13783267

Clinical experience with vinblastine sulfate.

O H WARWICK, R E ALISON, J M DARTE.   

Abstract

Entities:  

Keywords:  ALKALOIDS/therapy; ANTINEOPLASTIC AGENTS/therapy

Mesh:

Substances:

Year:  1961        PMID: 13783267      PMCID: PMC1848518     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.

Authors:  O H WARWICK; J M DARTE; T C BROWN; C T BEER; J H CUTTS; R L NOBLE
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

2.  Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action.

Authors:  J H CUTTS; C T BEER; R L NOBLE
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

3.  Effect of Vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women.

Authors:  R HERTZ; M B LIPSETT; R H MOY
Journal:  Cancer Res       Date:  1960-08       Impact factor: 12.701

4.  Role of chance observations in chemotherapy: Vinca rosea.

Authors:  R L NOBLE; C T BEER; J H CUTTS
Journal:  Ann N Y Acad Sci       Date:  1958-12-05       Impact factor: 5.691

5.  A study of Hodgkin's disease treated by irradiation.

Authors:  M V PETERS; K C MIDDLEMISS
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1958-01
  5 in total
  8 in total

1.  STUDIES ON THE SUPPRESSION OF IMMUNE RESPONSES BY THE PERIWINKLE ALKALOIDS VINCRISTINE AND VINBLASTINE.

Authors:  A C AISENBERG; B WILES
Journal:  J Clin Invest       Date:  1964-12       Impact factor: 14.808

2.  Chemotherapy of malignant disease: a review of theory and practice.

Authors:  G D HART
Journal:  Can Med Assoc J       Date:  1962-03-31       Impact factor: 8.262

3.  ANNOTATIONS.

Authors: 
Journal:  Br Med J       Date:  1962-01-13

4.  [Long term treatment of advanced lymphogranulomatosis with vinblastine sulfate].

Authors:  E Schulz; W Jüngling; K Hausmann
Journal:  Klin Wochenschr       Date:  1969-02-15

5.  O. Harold Warwick: Canada's first medical oncologist.

Authors:  D H Cowan
Journal:  Curr Oncol       Date:  2011-06       Impact factor: 3.677

Review 6.  Cancer chemotherapy: past, present, and future--Part I.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

7.  Clinical experience with vincaleukoblastine sulfate in the treatment of 11 patients with Hodgkin's disease.

Authors:  K R Butler
Journal:  Can Med Assoc J       Date:  1965-10-02       Impact factor: 8.262

8.  A comparison of nitrogen mustard and vinblastine sulfate in the treatment of patients with Hodgkin's disease.

Authors:  R E Alison; D M Whitelaw
Journal:  Can Med Assoc J       Date:  1970-02-14       Impact factor: 8.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.